Chemomab Therapeutics Ltd Adr (CMMB)

Oct 15, 2024

Chemomab reports progress in PSC treatment trial - Investing.com

Oct 15, 2024

Sep 20, 2024

Roth MKM Initiates Coverage of Chemomab Therapeutics LtdADR (CMMB) with Buy Recommendation - MSN

Sep 20, 2024

Sep 16, 2024

The Chemomab Therapeutics Ltd ADR (CMMB) had a good session last reading, didn’t it? - US Post News

Sep 16, 2024

Sep 13, 2024

Financial Health Check: Examining Chemomab Therapeutics Ltd ADR (CMMB)’s Key Ratios - The Dwinnex

Sep 13, 2024

Sep 09, 2024

Chemomab Therapeutics Ltd ADR (CMMB) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle

Sep 09, 2024

Sep 09, 2024

Ratios Uncovered: Breaking Down Chemomab Therapeutics Ltd ADR (CMMB)’s Trailing Twelve Months Metrics - The Dwinnex

Sep 09, 2024

Sep 04, 2024

Is Chemomab Therapeutics Ltd ADR (CMMB) a good investment opportunity? - US Post News

Sep 04, 2024

Sep 03, 2024

CMMB stock touches 52-week high at $2.07 amid market fluctuations - Investing.com

Sep 03, 2024

Aug 27, 2024

Chemomab Therapeutics Ltd ADR (CMMB) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Aug 27, 2024

Aug 27, 2024

Are Chemomab Therapeutics Ltd ADR (CMMB) shares a good deal now? - US Post News

Aug 27, 2024

Aug 26, 2024

CMMB stock touches 52-week high at $1.58 amid market fluctuations - Investing.com India

Aug 26, 2024

Aug 23, 2024

Chemomab Therapeutics Ltd ADR (CMMB) Stock: Uncovering 52-Week Market Trends - The InvestChronicle

Aug 23, 2024

Aug 21, 2024

Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.

Aug 21, 2024

Jul 26, 2024

Market Analysts see American Express Co. [AXP] gaining to $265. Time to buy? - The DBT News

Jul 26, 2024

Jul 26, 2024

Chemomab Therapeutics Ltd ADR [CMMB] moved down -16.20: Why It’s Important - The DBT News

Jul 26, 2024

Jul 26, 2024

Chemomab regains Nasdaq compliance with bid price rule - Investing.com

Jul 26, 2024

Jul 26, 2024

Public Service Enterprise Group Inc. [PEG] Revenue clocked in at $9.72 billion, up 21.41% YTD: What’s Next? - The DBT News

Jul 26, 2024

Jul 26, 2024

Cerevel Therapeutics Holdings Inc [CERE] Is Currently 2.37 below its 200 Period Moving Avg: What Does This Mean? - The DBT News

Jul 26, 2024

Jul 26, 2024

Ardelyx Inc [ARDX] moved down -2.31: Why It’s Important - The DBT News

Jul 26, 2024

Jul 25, 2024

CMMB’s 2023 Market Dance: Up 107.84% – Time to Invest? - The InvestChronicle

Jul 25, 2024

Jul 25, 2024

Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise - Benzinga

Jul 25, 2024

Jul 25, 2024

Chemomab secures $10 million in PIPE financing - Investing.com India

Jul 25, 2024

Jun 29, 2024

Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Now Trades Above Golden Cross: Time to Buy? - Yahoo News Malaysia

Jun 29, 2024

Jun 27, 2024

Chemomab Therapeutics (CMMB) Upgraded to Buy: Here's What You Should Know - MSN

Jun 27, 2024

May 17, 2024

Chemomab Therapeutics to Participate in Upcoming Scientific Conferences - Investing.com India

May 17, 2024

Apr 24, 2024

Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update - Investing.com India

Apr 24, 2024

Mar 26, 2024

LGVN Stock Quote Price and Forecast - CNN

Mar 26, 2024

Mar 25, 2024

Chemomab secures new European patent for liver disease treatment - Investing.com

Mar 25, 2024

Feb 14, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 14, 2024

Dec 06, 2023

Why Copart, Inc. (CPRT) is a Top Momentum Stock for the Long-Term - Zacks Investment Research

Dec 06, 2023

Jul 12, 2023

Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight - PR Newswire

Jul 12, 2023

Dec 03, 2021

Chemomab Stock: Leading Anti-CCL24 mAb For Fibrotic Diseases (NASDAQ:CMMB) - Seeking Alpha

Dec 03, 2021

Jun 24, 2021

Chemomab And AGC Biologics Partner To Manufacture CM-101 For Phase II/III - Contract Pharma

Jun 24, 2021

Mar 23, 2021

Chemomab Therapeutics (CMMB) Stock Price, News & Analysis - MarketBeat

Mar 23, 2021

Mar 18, 2021

Chemomab Therapeutics (NASDAQ:CMMB) Stock Quotes, Forecast and News Summary - Benzinga

Mar 18, 2021

Dec 16, 2020

The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal - Yahoo Finance

Dec 16, 2020